Nicolette, Inc., a digital health pioneer focused on patient education and data tools, today announced the US Patent and Trademark Office has issued a new patent (No.11,432,720). The patent protects Nicolette's NicoBoard technology, specifically the transformation of a patient's raw health data from their electronic health record (EHR) into easy-to-use tools such as tailored education content, natural-language insights, interactive visuals, and action prompts.
Nicolette first implemented NicoBoard in the neonatal intensive care unit (NICU) at CHOC Children's Hospital and has now served over 2,000 NICU families. A clinical study has been published showing breakthrough improvements in family input in care, quality of communication between families and clinicians, and timeliness of updates.
"From ideation to prototype to thousands of successful user experiences, our team has executed well by building tech that puts the patient at the center of care," says Phil Martie, co-founder and CEO at Nicolette. "This patent is an acknowledgment that we are the first to transform data in a truly patient-centric way, delivering it as an integrated part of healthcare."
Seth Brickman, co-founder and Chief Product Officer, adds, "The ability to transform a patient's raw health data into something that helps them and improves outcomes is what drives the Nicolette team. This patent recognizes the impact NicoBoard has on people's lives."
Nicolette's technology will continue to focus on NICU patients through 2023, with its first expansion to new inpatient departments near the end of the year. The patent extends to these new areas of growth.
Press Release Service by Newswire.com
Original Source: Nicolette, Inc. Awarded Patent for NicoBoard Technology
Free Electronic Health Records for Physicians
Bellmedex Company Logo
SEATTLE, January 30, 2023 (Newswire.com)
Dr. Todd Lanman shares his experience removing failed and solid fusions and placing artificial discs with a panel of artificial disc replacement spine surgeons.
AUSTIN, Texas, January 27, 2023 (Newswire.com)
Dr. Steven J. Dell at Dell Laser Consultants is the first in Austin, Texas, to treat cataract patients with t…
Dr. Saif Shere
Dr. Saif Shere of Brownstone Dental
HOUSTON, January 27, 2023 (Newswire.com)
Houstonians love their celebrities. But what if they could get the same treatment a celebrity gets when they visit the dentist? Brownstone Dental, founded by Dr. Saif Shere, is now offering the latest in dental technology and care to its patients with a new way to treat both general and cosmetic dental needs.
“We are so excited to offer this new opportunity for our patients,” said Dr. Shere. “I really believe that everyone deserves a chance to feel like they’re getting VIP treatment when they go to the dentist.”
Known for his expertise, Dr. Saif Shere graduated with honors and became a board-certified dentist in 2008. Later, in 2010, he founded his own practice – Brownstone Dental. After more than a decade of service, Dr. Saif Shere has earned the reputation of being Houston’s premier dental practitioner.
Many prominent personalities, including rappers and athletes, have had their teeth worked on by Dr. Shere. His patients come from all over the world because they know they can trust him to do the best work possible. Dr. Shere understands that people have different needs when it comes to their teeth, and he makes sure to take those needs into account at every appointment.
Dr. Shere is famous for treating his patients with a level of care that goes above and beyond what most dentists provide, but what sets him apart is his approach to cosmetic dentistry, which is all about innovation.
“I want to give them the Bollywood smile,” says Dr. Shere.
In an industry where most dentists are content with the same old procedures, he always looks for new ways to improve the smile of their patients. From advanced technology that allows him to offer the latest in dental techniques to the innovative use of customized methods, Dr. Shere has embraced the future of dentistry and uses it every day to help his patients get the perfect smile.
He went to Klein High School before attending the University of Houston and then Baylor College of Dentistry. If Dr. Shere wasn’t a celebrity dentist today, he would likely be teaching history at an esteemed university somewhere around town.
Shere’s first celebrity case was four years ago when he worked with a prominent rapper. In his own words, “Every patient is a celebrity to me! We treat all of our patients with extravagant care.”
Dr. Shere believes that when it comes to getting the best, there’s always room for improvement. With this in mind, he and his team have been working on new ways to help patients achieve their dream smile—one that offers more options than ever before.
For dental work that needs to be done soon, scheduling an appointment with Dr. Shere is possible at Brownstone Dental. They can be contacted at (713) 271-3000 or visited at 9824 Fondren Rd., Houston, TX 77096, United States.
The increasing need for interoperability in healthcare has driven significant growth and demand for the company’s data fabric platform and continued innovation in this area.
TORONTO, January 26, 2023 (Newswire.com)
Smile CDR Inc. (doing business as Smile Digital Health) (“Smile“), a leading FHIR® health data fabric (HDF) and exchange solutions provider, announced the closing of approximately $30 million in Series B growth capital led by existing investors including UPMC Enterprises.
Smile’s HDF platform uses industry-leading HDF architecture and ONC-compliant, event-driven FHIR APIs to allow healthcare providers, payers and IT vendors to build secure, composable and scalable data infrastructures. Smile offers a suite of health data, clinical reasoning and marketplace utilities that can support ecosystem-wide data innovation and digital modernization efforts to accelerate healthcare innovation, improve quality of patient care journeys, boost operational efficiencies and reduce costs using intelligent automation implementation strategies.
“Our vision for better global health becomes more achievable when we focus on the inherent value of finding innovative ways to efficiently share and use data. Smile Digital Health has seen significant growth in our platform because it does just this. With transformative solutions that can meet companies’ specific needs, we are preparing healthcare providers, payers, researchers and life sciences organizations for a connected future that transcends the capabilities of today’s systems,” said Duncan Weatherston, Chief Executive Officer at Smile Digital Health.
Smile Digital Health is committed to continuing its advancements in end-to-end interoperability with expanded offerings that enhance the breadth of its data fabric solutions for future digital transformations. The company will use this new round of funding to expand its newly acquired clinical reasoning utility and forward-looking artificial intelligence and machine learning capabilities, further advancing Smile Digital Health as the leader in the field.
“Data fabrics open up many new ways of leveraging and working with health data. We will continue to delve into creating solutions that drive change in healthcare and enable better outcomes for everyone. We will also optimize our solutions, as new regulations and mandates are passed, consistently maintaining offerings that keep payers and providers compliant. When new innovations emerge in the industry, we will look at ways to leverage those in the HDF platform and through our add-on solutions to drive value through data,” said Weatherston.
“Successfully raising $30 million in such a challenging capital markets environment is a testament to the strength and desirability of Smile’s technological offering and the broad appeal of the vision of its founders,” commented Smile Digital Health Chairman, George Rizk.
In 2022, Smile was cited by The Globe and Mail’s ranking of Canada’s Top Growing Companies. It was also recognized as a 2022 Deloitte Technology Fast 50™ and North America Technology Fast 500™ company for the second year running.
“Smile is a leader in the Health Data Fabric space and is a highly innovative and client-focused company looking to improve healthcare through access to digital information. Its work with Astrata, a company created by UPMC Enterprises, demonstrates Smile’s ability to deliver value to many parties in the health ecosystem,” said Brent Burns, Executive Vice President at UPMC Enterprises, the venture capital and commercialization arm of leading health system UPMC. “UPMC shares the same passion as Smile for improving healthcare via innovation.”
Smile Digital Health has grown rapidly from a 2016 start-up to being a recognized leader in the digital health solutions space, servicing clients across the healthcare spectrum, including many top tier payers and providers across the United States and 18 other countries, as well as research institutions, other health information technology companies and government agencies.
Smile’s legal advisors in conjunction with this financing were Davies Ward Phillips & Vineberg LLP.
About Smile Digital Health
Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, open framework data fabric and integration platform fuels healthcare’s digital transformation and accelerates value creation across all patient journeys at scale. our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate and meaningfully share the health information to power digital transformation. We prepare healthcare providers, payers, researchers and life sciences organizations for a connected future beyond legacy systems, adding new value through intelligent use of information and ultimately delivering better patient outcomes. For more information, visit: SmileDigitalHealth.com.
Acting Director of Marketing
(877) 537-3343 x 728
Creator of wearable sustained acoustic medicine technology to educate clinicians on device’s effectiveness in soft tissue healing and regenerative medicine treatment.
LAS VEGAS, January 26, 2023 (Newswire.com)
ZetrOZ Systems will demonstrate the effectiveness of its sam®x1 and sam®2.0 sustained acoustic medicine devices for soft tissue injury therapies at the Las Vegas Regenerative Medicine and MSK Ultrasound Course, the longest-running medical education seminar of its kind, from Jan. 26 to 28 in Las Vegas.
The sam®x1 is the first FDA-cleared pain management device of its kind cleared for everyday, at-home use, and the sam®2.0 is the long-duration solution. Both are wearable pain relief ultrasound devices that inhibit inflammation and accelerate natural healing by stimulating tissue regeneration, increasing circulation, and nutrient exchange in deep musculoskeletal tissue.
The multiple-day educational course, at the Planet Hollywood Resort and Casino, Las Vegas, welcomes hundreds of practitioners as varied as orthopedic surgeons, sports medicine physicians, PM&R physicians, pain management physicians, interventional radiologists, rheumatologists, physical therapists, naturopathic doctors, chiropractors, podiatrists, physician assistants, nurse practitioners, diagnostic sonographers and more.
“The Las Vegas Regenerative Medicine and MSK Ultrasound Course brings in leading physicians and other practitioners who will speak on the administration of ultrasound technology and its many benefits – it offers patients options beyond pain medication or surgery,” says Dr. George Lewis, founder and CEO of ZetrOZ Systems. “We’re incredibly excited to attend and bring awareness of our innovative pain relief ultrasound device portfolio to more healthcare professionals.”
The first day of the program will be dedicated to reviewing scientific updates, new regulations, and best practices of the orthopedic discipline. The last two days will focus on practical ultrasound operation, and ZetrOZ Systems sam®x1 and sam®2.0 will be joining the lineup of medical treatment options available for clinicians to review and apply.
Backed by more than 30 clinical studies, sam® technology was developed with research funded by the National Institutes of Health and the U.S. Department of Defense with the intent of finding new methods of soft tissue healing that reduce the use of narcotics and invasive treatments.
To learn more about sustained acoustic medicine and its effectiveness in soft tissue healing, visit zetroz.com.
About ZetrOZ Systems
ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of +46 patents. The exclusive manufacturer and developer of the sam® product line is designed for the treatment of acute and chronic musculoskeletal conditions.